Delivery Order SPE2DB24D3013-SPE2DB25FFPAV
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Exforge 10-160 mg tablets (30-count units) with a ceiling value of $4,993.49. This firm fixed-price delivery order, which is not set-aside and will be completed by July 24, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency awarded a $16,889.00 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Exforge 10-320 mg, a combination antihypertensive medication. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child delivery order under a larger indefinite delivery contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,992.17 to AmerisourceBergen Drug Corp for Exforge 10-160 mg tablets (30-count supply) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $1,826.35 to AmerisourceBergen Drug Corp for EXFORGE 5-160 MG tablets (30-count supply) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,393.26 firm fixed-price delivery order is for the supply of Exforge 10-320 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.49 firm-fixed-price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has a ceiling value of $1,126.49 and a period of performance through March 12, 2025. This delivery order is part of a larger Indefinite Delivery...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a medication, with a ceiling value of $1,070.31 and a completion date of June 27, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of EXFORGE 5-320 MG TABLET 30S. The order, valued at $2,368.71, is a firm fixed-price contract with a completion date of September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...